OUR STORY

PREDICTIX was developed by the health-technology startup, Taliaz, led by brothers Dekel and Oren Taliaz, in 2015.  Following Dekel’s PhD in Neuroscience from the Weizman Institute in Israel, PREDICTIX was born on the idea that by harnessing advances in deep learning technologies within the neuroscience sector, we can create new approaches to personalize medicine and transform mental health care. 

PREDICTIX Genetics is CE approved and commercially available in the UK and Israel. Clinical studies are also being conducted with leading healthcare organizations, including Hôpital Pitié-Salpêtrière and Maccabi Healthcare Services, the second largest health medical organization in Israel.

We believe that only by smartly harnessing science combined with deep data analytics are we capable of understanding the intricate relationships between both our real-world experience and within our brain. As PREDICTIX is used, our algorithms learn from these new data sets to further optimize treatment to meet the evolving needs of patients. 

Packaged for physicians and patients in an easy-to-use, non-invasive and straightforward way, PREDICTIX turns complex technology into real-world practical products. This unique scientific-analytical approach enables the PREDICTIX platform to transform treatment and management in a range of mental health conditions and beyond!